Liu Bo, Zhang Dengyun, Wang He, Wang Hexiang, Zhang Pengfei, Zhang Dawei, Zhang Qun, Zhang Jian
Department of Gastrointestinal Surgery, the Affiliated Hospital of Qingdao University, Qingdao, China.
Department of Radiology, the Affiliated Hospital of Qingdao University, Qingdao, China.
Quant Imaging Med Surg. 2022 Nov;12(11):5222-5238. doi: 10.21037/qims-22-286.
The accuracy of preoperative staging is crucial for cT4 stage gastric cancer patients. The aim of this study was to develop the radiomics model and evaluate its predictive potential for differentiating preoperative cT4 stage gastric cancer patients into pT4b and no-pT4b patients.
A multicenter retrospective analysis of 704 gastric cancer patients with preoperative contrast-enhanced computed tomography (CE-CT) staging cT4 between January 2008 and December 2021. These patients were divided into the training cohort (478 patients, the Affiliated Hospital of Qingdao University) and validation cohort (226 patients, the Weihai Wendeng District People's Hospital). According to the pathological stage of the tumors, the patients were divided into pT4b or no-pT4b stage. In the training cohort, the clinical and radiomics features were analyzed to construct the clinical model, tri-phase radiomics signatures and nomogram. Two kinds of methods were employed to achieve dimensionality reduction: (I) the least absolute shrinkage and selection operator (LASSO); and (II) the minimum redundancy maximum relevance (mRMR) algorithms. We utilized Logistic regression, support vector machine (SVM), Decision tree and Adaptive boosted tree (AdaBoost) algorithms as the machine learning classifiers. The nomogram was constructed on the clinical characteristics and the Rad-score. The performance of the models was evaluated by receiver operating characteristic (ROC) area under the curve (AUC), Decision Curve Analysis (DCA) curve and calibration curve.
The 345 pT4b and 359 no-pT4b stage patients were included in this study. In the validation cohort, the AUC of the clinical model was 0.793 (95% CI: 0.732-0.855). The tri-phase radiomics features combined with the SVM algorithm was the best radiomics signature with an AUC of 0.862 (95% CI: 0.812-0.912). The nomogram was the best predictive model of all with an AUC of 0.893 (95% CI: 0.834-0.927). In the training and validation cohorts, the calibration curves and DCA curves of the nomogram showed satisfactory result.
CE-CT-based radiomics nomogram offers good accuracy and stability in differentiating preoperative cT4 stage gastric cancer patients into pT4b and non-pT4b stages, which has a great clinical relevance for selecting the course of treatment for cT4 stage gastric cancer patients.
术前分期的准确性对于cT4期胃癌患者至关重要。本研究的目的是建立放射组学模型,并评估其在区分术前cT4期胃癌患者为pT4b和非pT4b患者方面的预测潜力。
对2008年1月至2021年12月期间704例术前经对比增强计算机断层扫描(CE-CT)分期为cT4的胃癌患者进行多中心回顾性分析。这些患者被分为训练队列(478例患者,青岛大学附属医院)和验证队列(226例患者,威海文登区人民医院)。根据肿瘤的病理分期,将患者分为pT4b期或非pT4b期。在训练队列中,分析临床和放射组学特征以构建临床模型、三相放射组学特征和列线图。采用两种方法进行降维:(I)最小绝对收缩和选择算子(LASSO);(II)最小冗余最大相关(mRMR)算法。我们使用逻辑回归、支持向量机(SVM)、决策树和自适应增强树(AdaBoost)算法作为机器学习分类器。根据临床特征和Rad评分构建列线图。通过曲线下面积(AUC)、决策曲线分析(DCA)曲线和校准曲线评估模型的性能。
本研究纳入了345例pT4b期和359例非pT4b期患者。在验证队列中,临床模型的AUC为0.793(95%CI:0.732-0.855)。三相放射组学特征与SVM算法相结合是最佳的放射组学特征,AUC为0.862(95%CI:0.812-0.912)。列线图是所有模型中最佳的预测模型,AUC为0.893(95%CI:0.834-0.927)。在训练和验证队列中,列线图的校准曲线和DCA曲线显示出令人满意的结果。
基于CE-CT的放射组学列线图在区分术前cT4期胃癌患者为pT4b和非pT4b期方面具有良好的准确性和稳定性,这对于选择cT4期胃癌患者的治疗方案具有重要的临床意义。